PARIS--(BUSINESS WIRE)--Medical device pioneer Stentys announced today that clinical results from the ‘OPEN I’ clinical study using its bifurcated stent will be presented at this week’s ‘EuroPCR 2008’ international medical meeting on cardiovascular intervention. The data, to be presented by Eberhard Grube, M.D., Chief of Cardiology and Angiology at HELIOS Heart Center (Germany) and Principal Investigator of the OPEN I study, will look at safety results after 30 days post-implantation of the Stentys bifurcated stent in the first 13 patients.
